All In Biotech

Free tool

FAERS Monitor: Venofer

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021135 or its brand name (Venofer, Iron Sucrose). Reports on generic versions are filed under their own applications.

Reports

9,664

Serious

7,633

79% of reports

Hospitalization

3,293

Death reported

935

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug hypersensitivity1,169
  • nausea1,035
  • dyspnoea1,014
  • off label use654
  • pruritus651
  • vomiting647
  • diarrhoea554
  • rash550
  • hypotension530
  • dizziness520
  • urticaria495
  • headache473
  • malaise464
  • infusion related reaction462
  • arthralgia459

Reports by year received

View as table
YearReports
200448
200568
200686
2007141
2008157
2009270
2010240
2011190
2012269
2013299
2014277
2015384
2016444
2017420
2018485
2019843
2020589
2021690
2022904
2023814
2024716
2025704
2026626

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,495 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion related reactionSignal46215.314.06,123
drug hypersensitivitySignal1,16913.212.513,236
urticariaSignal4956.45.92,284
hypotensionSignal5305.85.32,096
dyspnoeaSignal1,0143.93.72,244
pruritusSignal6513.73.41,296
vomitingSignal6473.02.8878
nauseaSignal1,0352.82.71,287
rashSignal5502.72.5622
arthralgiaSignal4592.42.2382
malaiseSignal4642.32.1348
dizzinessSignal5202.32.1377
diarrhoea5541.91.7230
headache4731.61.5122
off label use6541.61.5164

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.